Date published: 2025-11-25

1-800-457-3801

SCBT Portrait Logo
Seach Input

Atonal Inhibitors

Chemical inhibitors of atonal function through various signaling pathways, each with specific molecular targets. Cyclopamine acts by directly binding to the Smoothened (SMO) receptor, integral to the Hedgehog signaling pathway. This interaction inhibits the pathway's ability to promote atonal expression by suppressing downstream gene transcription. LY294002 targets the phosphoinositide 3-kinases (PI3K), reducing Akt phosphorylation and its associated activity, which can decrease the expression or activity of atonal. U0126 takes a different approach by inhibiting MEK1/2, thereby obstructing the MAPK/ERK signaling pathway, which can influence transcription factors and cellular processes that involve atonal. DAPT contributes to inhibition by preventing the cleavage of Notch receptors through its action as a gamma-secretase inhibitor, thus indirectly affecting atonal by altering cell fate determination processes regulated by Notch signaling. Further, SB431542 inhibits the TGF-beta receptor ALK5, thereby impeding the TGF-beta signaling that could influence atonal activity. PD98059, similar to U0126, blocks the MAPK/ERK pathway, affecting transcription factor activities and cellular processes where atonal may play a role. SP600125 disrupts the JNK signaling pathway, which is associated with cell fate decisions and could thereby modulate atonal function. NSC23766 specifically inhibits Rac1, which can impact cytoskeletal organization and other cellular processes linked to atonal. Y-27632 inhibits ROCK, part of the pathway that regulates actin cytoskeleton dynamics, indirectly affecting atonal's role. XAV-939 acts by inhibiting the Wnt pathway, thus influencing cell fate determination and differentiation processes where atonal is active. Wortmannin, like LY294002, inhibits PI3K but does so by preventing PIP3 formation, which leads to decreased AKT signaling and can affect atonal expression or activity. Lastly, Rapamycin inhibits mTOR, a regulator of cell growth and proliferation, which can have an indirect effect on cellular processes involving atonal. Each of these chemicals, by targeting specific components of cellular signaling pathways, can alter the functional context and activity of atonal without directly interacting with the protein itself.

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Cyclopamine

4449-51-8sc-200929
sc-200929A
1 mg
5 mg
$92.00
$204.00
19
(1)

Inhibits the Hedgehog (Hh) signaling pathway by binding to and inhibiting the Smoothened (SMO) protein, which is crucial for the activation of the Hh pathway, leading to the suppression of downstream gene transcription that would otherwise promote atonal expression.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$121.00
$392.00
148
(1)

Inhibits phosphoinositide 3-kinases (PI3K), leading to reduced Akt phosphorylation and activity. This inhibition may downregulate cell survival and proliferation signals, which can decrease the cellular contexts in which atonal might be upregulated or necessary for function.

U-0126

109511-58-2sc-222395
sc-222395A
1 mg
5 mg
$63.00
$241.00
136
(2)

Inhibits MEK1/2, leading to a blockade of the MAPK/ERK signaling pathway. Since MAPK/ERK signaling can regulate a variety of transcription factors and cellular processes that may involve atonal, inhibition by U0126 can suppress the functional context where atonal is active.

DAPT

208255-80-5sc-201315
sc-201315A
sc-201315B
sc-201315C
5 mg
25 mg
100 mg
1 g
$99.00
$335.00
$836.00
$2099.00
47
(3)

Gamma-secretase inhibitor that prevents the cleavage of many substrates, including Notch receptors. Given that Notch signaling can regulate neurogenesis and the expression of genes like atonal, DAPT can indirectly inhibit the atonal protein's functional role by altering cell fate determination.

SB 431542

301836-41-9sc-204265
sc-204265A
sc-204265B
1 mg
10 mg
25 mg
$80.00
$212.00
$408.00
48
(1)

Inhibitor of the TGF-beta receptor ALK5, which leads to the inhibition of the TGF-beta signaling pathway. TGF-beta signaling can influence the development and differentiation of various cell types, potentially including those where atonal is active, thereby inhibiting its functional role.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$39.00
$90.00
212
(2)

MEK inhibitor that blocks the MAPK/ERK pathway. By inhibiting this pathway, PD98059 can reduce the activity of transcription factors and processes that would otherwise support the functional environment for atonal's role in cell differentiation.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

Inhibits the JNK signaling pathway, which is involved in controlling a number of cellular processes, including cell fate decisions. Inhibition of JNK signaling by SP600125 can thus indirectly inhibit the cellular processes that depend on atonal.

Y-27632, free base

146986-50-7sc-3536
sc-3536A
5 mg
50 mg
$182.00
$693.00
88
(1)

Inhibits the Rho-associated protein kinase (ROCK), which can regulate actin cytoskeleton dynamics. By inhibiting ROCK, Y-27632 can indirectly inhibit cellular processes that might be necessary for atonal's role in cell morphology and differentiation.

XAV939

284028-89-3sc-296704
sc-296704A
sc-296704B
1 mg
5 mg
50 mg
$35.00
$115.00
$515.00
26
(1)

Inhibits the Wnt pathway by stabilizing Axin and promoting beta-catenin degradation. Since Wnt signaling is crucial for various aspects of cell fate determination and differentiation, inhibition by XAV-939 can indirectly reduce the functional context in which atonal operates.

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$66.00
$219.00
$417.00
97
(3)

PI3K inhibitor that prevents the formation of PIP3, thus inhibiting AKT phosphorylation and signaling. Reduced AKT activity by Wortmannin can diminish survival and proliferation signaling, indirectly inhibiting the cellular environment where atonal is functional.